PortfoliosLab logo
APLD vs. HALO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between APLD and HALO is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

APLD vs. HALO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Applied Digital Corporation (APLD) and Halozyme Therapeutics, Inc. (HALO). The values are adjusted to include any dividend payments, if applicable.

0.00%500.00%1,000.00%1,500.00%December2025FebruaryMarchAprilMay
-55.81%
1,550.35%
APLD
HALO

Key characteristics

Sharpe Ratio

APLD:

0.51

HALO:

1.70

Sortino Ratio

APLD:

1.78

HALO:

2.37

Omega Ratio

APLD:

1.21

HALO:

1.36

Calmar Ratio

APLD:

0.75

HALO:

2.23

Martin Ratio

APLD:

2.56

HALO:

5.90

Ulcer Index

APLD:

28.61%

HALO:

12.84%

Daily Std Dev

APLD:

144.19%

HALO:

44.56%

Max Drawdown

APLD:

-99.99%

HALO:

-74.26%

Current Drawdown

APLD:

-95.11%

HALO:

0.00%

Fundamentals

Market Cap

APLD:

$1.19B

HALO:

$7.56B

EPS

APLD:

-$1.47

HALO:

$3.43

PS Ratio

APLD:

5.38

HALO:

7.38

PB Ratio

APLD:

2.62

HALO:

20.78

Total Revenue (TTM)

APLD:

$221.19M

HALO:

$819.45M

Gross Profit (TTM)

APLD:

$12.34M

HALO:

$670.60M

EBITDA (TTM)

APLD:

-$46.07M

HALO:

$530.80M

Returns By Period

In the year-to-date period, APLD achieves a -31.28% return, which is significantly lower than HALO's 46.71% return. Over the past 10 years, APLD has outperformed HALO with an annualized return of 110.08%, while HALO has yielded a comparatively lower 16.27% annualized return.


APLD

YTD

-31.28%

1M

-0.19%

6M

-25.74%

1Y

69.35%

5Y*

186.65%

10Y*

110.08%

HALO

YTD

46.71%

1M

18.18%

6M

15.69%

1Y

70.20%

5Y*

24.44%

10Y*

16.27%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

APLD vs. HALO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APLD
The Risk-Adjusted Performance Rank of APLD is 7777
Overall Rank
The Sharpe Ratio Rank of APLD is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of APLD is 8282
Sortino Ratio Rank
The Omega Ratio Rank of APLD is 7878
Omega Ratio Rank
The Calmar Ratio Rank of APLD is 7979
Calmar Ratio Rank
The Martin Ratio Rank of APLD is 7676
Martin Ratio Rank

HALO
The Risk-Adjusted Performance Rank of HALO is 9191
Overall Rank
The Sharpe Ratio Rank of HALO is 9393
Sharpe Ratio Rank
The Sortino Ratio Rank of HALO is 9090
Sortino Ratio Rank
The Omega Ratio Rank of HALO is 9292
Omega Ratio Rank
The Calmar Ratio Rank of HALO is 9494
Calmar Ratio Rank
The Martin Ratio Rank of HALO is 8989
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

APLD vs. HALO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Applied Digital Corporation (APLD) and Halozyme Therapeutics, Inc. (HALO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current APLD Sharpe Ratio is 0.51, which is lower than the HALO Sharpe Ratio of 1.70. The chart below compares the historical Sharpe Ratios of APLD and HALO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.50December2025FebruaryMarchAprilMay
0.49
1.59
APLD
HALO

Dividends

APLD vs. HALO - Dividend Comparison

Neither APLD nor HALO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

APLD vs. HALO - Drawdown Comparison

The maximum APLD drawdown since its inception was -99.99%, which is greater than HALO's maximum drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for APLD and HALO. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-82.71%
0
APLD
HALO

Volatility

APLD vs. HALO - Volatility Comparison

Applied Digital Corporation (APLD) has a higher volatility of 54.12% compared to Halozyme Therapeutics, Inc. (HALO) at 20.39%. This indicates that APLD's price experiences larger fluctuations and is considered to be riskier than HALO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%December2025FebruaryMarchAprilMay
54.12%
20.39%
APLD
HALO

Financials

APLD vs. HALO - Financials Comparison

This section allows you to compare key financial metrics between Applied Digital Corporation and Halozyme Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M20102012201420162018202020222024
52.92M
298.01M
(APLD) Total Revenue
(HALO) Total Revenue
Values in USD except per share items

APLD vs. HALO - Profitability Comparison

The chart below illustrates the profitability comparison between Applied Digital Corporation and Halozyme Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20102012201420162018202020222024
7.1%
85.9%
(APLD) Gross Margin
(HALO) Gross Margin
APLD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Applied Digital Corporation reported a gross profit of 3.78M and revenue of 52.92M. Therefore, the gross margin over that period was 7.1%.

HALO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Halozyme Therapeutics, Inc. reported a gross profit of 255.95M and revenue of 298.01M. Therefore, the gross margin over that period was 85.9%.

APLD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Applied Digital Corporation reported an operating income of -18.94M and revenue of 52.92M, resulting in an operating margin of -35.8%.

HALO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Halozyme Therapeutics, Inc. reported an operating income of 175.50M and revenue of 298.01M, resulting in an operating margin of 58.9%.

APLD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Applied Digital Corporation reported a net income of -35.56M and revenue of 52.92M, resulting in a net margin of -67.2%.

HALO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Halozyme Therapeutics, Inc. reported a net income of 137.01M and revenue of 298.01M, resulting in a net margin of 46.0%.